Equity Research, Broker Reports, and media content on Kromek Group Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Kromek Group Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard
  • 16 May 22
Kromek Group’s Arnab Basu sees “continued commercial traction and robust demand”
kromek-group-s-arnab-basu-sees-continued-commercial-traction-and-robust-demand-
  • 16 May 22
Trading update: FY23 targets remain on course

In a Trading Update for the year to 30 April 2022 Kromek reports that it expects FY22 revenue of £12.1m. This compares to our previous FY22 forecast of £15.0m. However, for the current year, backed by strong contract visibility, our FY23 expectation of £18.0m revenues remains unchanged. As outlined at the interims, the Group continued to be impacted by supply chain issues, notably the availability of key components required to complete £2.9m of orders required by the year end. These orders are

Companies: Kromek Group Plc
  • 16 May 22
Morning Note – 16 May 2022


Companies: Kromek Group Plc (KMK:LON)Synairgen plc (SNG:LON)
  • 16 May 22
Kromek - Technology enabler for next generation medical imaging

Kromek is an enabling technology provider to the medical imaging market in particular. It is a commercial-stage company with two significant high growth opportunities: as a critical component supplier of cadmium zinc telluride (CZT) detectors to the advanced medical imaging market (next generation SPECT and CT modalities); and as a manufacturer of state-of-the-art radiation detectors to global government and Homeland Security agencies. High barriers to entry, given c.£130m invested since incepti

Companies: Kromek Group Plc
  • 04 Apr 22
Hybridan Small Cap Feast 04/04/22

Joiners: Asimilar Group plc (ASLR.L), currently listed on AIM, has joined the Aquis Stock Exchange Growth Market (Access Segment). The Group invests in the technology and software sectors and aims to focus primarily on opportunities in the Big Data, Machine Learning, Telematics and Internet of Things areas. Whilst the Directors are principally focused on making investments in private businesses, they do not rule out investments in listed businesses if this presents, in their judgment, the best o

Companies: NEXS THR OEX LIKE 1690548D KMK GML AXL ECK

  • 18 Jan 22
Kromek Group reports a 'solid first half' and remains 'on track to delivering significant growth'
kromek-group-reports-a-solid-first-half-and-remains-on-track-to-delivering-significant-growth-
  • 18 Jan 22
Cenkos: Kromek Group Plc -- Imaging ramp

Kromek is on track for +45% YoY revenue growth in FY22E, over which it has very strong visibility. Component supply issues seen in 2021 have been ameliorated, and flattish H1A revenues belie a deferral of deliveries into H2E which have now been made. Kromek's markets are rapidly recovering and FY22E will generate a record revenue base for the Group.

Companies: Kromek Group Plc
  • 18 Jan 22
Established leader in detection solutions

Kromek delivered a sound, well-managed, H1 performance given industry-wide supply chain and components difficulties and inflationary costs, whilst preserving a healthy cash balance. It reported increased activity in the key medical imaging segment, with three new strategic OEMs, plus the receipt of multi-million-dollar contracts in CBRN (chemical, biological, radiological, nuclear) segment. The six months to 31 October 2021 saw: revenue of £4.71m +2.9%YoY, with gross margin at 46.8% (FY21: 48

Companies: Kromek Group Plc
  • 26 Oct 21
Kromek Group 'very excited' after securing seven-year agreement for first generation of product
kromek-group-very-excited-after-securing-seven-year-agreement-for-first-generation-of-product
  • 26 Oct 21
$17m contract win with major US based OEM

Bringing truly transformational, hi-tech products (eg autonomous driving) to market often takes years from initial R&D, fine-tuning & prototyping, right through to extensive field-trials and ‘proof-of-concept’. Only then to fail at either final customer sign-off or regulatory approval. Not so Kromek. Saying today that it had been awarded a 7 year $17m contract with a large US OEM to supply next generation CZT detectors to identify contaminants within production processes for quality inspection p

Companies: Kromek Group Plc
  • 28 Sep 21
Cenkos: Kromek Group Plc -- Redlen acquisition leaves Kromek stronger

Canon Inc has acquired Redlen Technologies, the only independent commercial producer of CZT detectors globally other than Kromek. Kromek's Medical Imaging division competes against Redlen in the medical imaging market and this consolidation leaves Kromek as the sole independent producer of CZT detectors worldwide. The read-across valuation for this division alone suggests Kromek is materially undervalued, and we see fair value in excess of 50p.

Companies: Kromek Group Plc
  • 23 Sep 21
Hybridan Small Cap Feast 23/09/2021

Joiners No joiners today. Leavers John Laing Group has left the Official List (premium) What’s cooking in the IPO kitchen? Eurowag confirms its intention to undertake an initial public offering on the Main Market (Premium). The Offer would be expected to comprise both (i) new Ordinary Shares to be issued by the Company, raising gross proceeds of approximately EUR200m to support Eurowag's growth strategy and (ii) existing Ordinary Shares to be sold by existing Eurowag shareholders. Eurowag is a l

Companies: CFCP CIC KIBO KMK PEG QFI

  • 23 Sep 21
Hybridan Small Cap Feast 23-09-2021

Eurowag confirms its intention to undertake an initial public offering on the Main Market (Premium). The Offer would be expected to comprise both (i) new Ordinary Shares to be issued by the Company, raising gross proceeds of approximately EUR200m to support Eurowag's growth strategy and (ii) existing Ordinary Shares to be sold by existing Eurowag shareholders. Eurowag is a leading pan-European integrated payments & mobility platform focused on the commercial road transportation industry. It make

Companies: CFCP CIC ENW IOG KIBO KIST KMK PEG QFI BHC

  • 14 Jul 21
Kromek Group: 'Entered this year with great visibility, strong balance sheet and very good pipeline'
kromek-group-entered-this-year-with-great-visibility-strong-balance-sheet-and-very-good-pipeline-
  • 14 Jul 21
Cenkos: Kromek Group Plc -- Proper RoI ahead

Recent news flow and positive contract momentum is sufficient to provide investors with high visibility over a 45% growth rate. This growth rate will produce a record revenue base this year but the advent of supplemental market opportunities in new product areas means the demand curve facing Kromek is now at its steepest. Buy.

Companies: Kromek Group Plc

Kromek Group Plc

Company Profile

  • Personnel
  • Arnab Basu , CEO
  • Derek Bulmer, CFO
  • Peter Williams, Chairman

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Kromek Group Plc. We currently have 93 research reports from 7 professional analysts.

Latest News/RNS

(more news)
Date Source Announcement
16May22 12:07 RNS Kromek Group PLC - Director Share Purchase
16May22 07:00 RNS Kromek Group PLC - Appointment of Nominated Adviser and Broker
16May22 07:00 RNS Kromek Group PLC - Business and Trading Update
04Apr22 07:00 RNS Kromek Group PLC - New £1.7m CBRN contract
18Jan22 07:00 RNS Kromek Group PLC - Interim Results
17Dec21 16:41 RNS Kromek Group PLC - Second Price Monitoring Extn
17Dec21 16:35 RNS Kromek Group PLC - Price Monitoring Extension
Get free RNS email alerts

  • Frequency of research reports

     

  • Research reports on

    Kromek Group Plc

  • Providers covering

    Kromek Group Plc

  • 20 May 22
Cenkos: Healthcare Sector - Ward Round

Weekly round-up of AIM-listed healthcare news. Venture Life Group, GENinCode, Kromek, Alliance Pharma, Polarean Imaging, Benchmark Holdings, Ondine Biomedical, Verici Dx, Faron Pharmaceuticals, Avacta Group, Abingdon Health, Open Orphan, Belluscura, Hutchmed (China), Oxford Biodynamics

Companies: ANIC RUA CREO GENI HEIQ IHC IXI IUG OPTI SBTX VAL VLG

  • 12 May 22
Cenkos: Concurrent Technologies Plc -- FY21 Final results update

FY21 revenues of £20.5m were 5.1% ahead of forecasts, with gross margin increased 2.2% to 55.9% and PBT up 17% to £3.5m. R&D is accelerating with a focus on increasing the product range at double the previous frequency and within half the time. Order in-take is strong, though revenues in FY22E will be affected by the widely reported electronic component availability. However, with this growing order in-take and significant balance sheet strength, Concurrent is strongly positioned to continue to

Companies: Concurrent Technologies Plc
  • 13 May 22
Cenkos: Healthcare Sector -- Ward Round

Weekly round-up of AIM-listed healthcare news. Agronomics, Eden Research, IXICO, HeiQ, Trellus Health, NetScientific, Circassia, 4basebio, Fusion Antibodies, Surgical Innovations Group, Yourgene Health, Abingdon Health, Verici Dx, Poolbeg Pharma, Omega Diagnostics

Companies: ANIC RUA CREO GENI HEIQ IHC IXI IUG OPTI SBTX VAL VLG

  • 20 May 22
Hybridan Small Cap Feast 20/05/22

Dish of the day Joiners: No Joiners Today. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? Psych Capital PLC, intends to list on the AQSE Growth Market. Psych operates the Psych Platform (a business-to-business networking platform), that is developing the Blossom Database pursuant to a third party licensing arrangement. The Company also has an investment of 426,000 common shares in Awakn, a Canadian NEO Exchange listed psychedelics research and clinical group, with operations in th

Companies: YCA 7DIG BOOM DMTR EYE KIBO NFC RST SPSY

  • 29 Apr 22
Cenkos: Brave Bison Group Plc -- Charging Ahead

Brave Bison has released its full-year results in-line with previous guidance. The company has had a transformational year with the new management team putting the business on a firmly profitable path having turned a statutory profit in FY21A for the first time along with 50% revenue growth. They carried out their valuable acquisition of Greenlight, a UK digital advertising and technology firm, which broadened and complemented the Brave Bison offering. Today, the company have announced a further

Companies: Brave Bison Group Plc
  • 18 May 22
Morning Note – 18 May 2022


Companies: ARB D4T4 ORPH SPE

  • 09 May 22
LIBERUM: Cerillion* - Strong momentum into H2


Companies: Cerillion Plc
  • 17 May 22
FY22 AOP ahead of expectations

Having updated in April that FY22 revenues and operating profits were expected to be in line with consensus, Eckoh today updates that operating profits grew strongly in the period and will now be ahead of consensus. Revenues are expected to be in line. We suspect this means operating profits will be slightly above £5.0m compared to our forecasts of £4.9m. This de-risks our FY23 forecasts, where we are looking for AOP of £7.7m. We are forecasting FY23 AOP of £5.9m from the existing business, up f

Companies: Eckoh plc
  • 17 May 22
FY22 in line, further strong growth expected in FY23

Despite lingering lockdown headwinds, FYJan22 saw continued strong growth for Smartspace’s two SaaS businesses, SwipedOn (visitor, employee and desk management) and Space Connect (meeting room and desk management), driving combined ARR up 64% organic to £4.9m. SwipedOn ARR grew 57% yoy (>85% of total ARR) with Space Connect ARR up almost threefold. Encouraging trading through to end April (ARR rose to £5.5m) underpins Smartspace’s continued expectations for “further strong growth in FY23”. Key d

Companies: Smartspace Software Plc
  • 13 May 22
Hybridan Small Cap Feast 13/05/22

Dish of the day Joiners: GS Chain (GSC) has joined the Main Market (Standard). GS Chain intends to identify opportunities within the technology sector, to conduct the necessary due diligence and subsequently complete an Acquisition. The Company is direct listing 399,985,888 Ordinary Shares on the Official List. Market capitalisation at 1p is £3,999,858.88. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? According to CITY A.M online marketplace Beauty Bay has recruited bankers to lo

Companies: FPO NMT RBD SNT SOLG HUI FCRM AEX

  • 18 May 22
Hybridan Small Cap Feast 18/05/22

Dish of the day Joiners: Lekoil, the oil and gas exploration and production Company with a focus on Nigeria and West Africa has joined the Access Segment of the AQSE Growth Market. The Company was previously listed on AIM (LEK.L), however, Ordinary Shares have been suspended from trading on AIM since October 2021. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? Psych Capital PLC, intends to list on the AQSE Growth Market. Psych operates the Psych Platform (a business-to-business ne

Companies: CZA AXL AEE CORA D4T4 EKF ORPH PWM PPH SYM

  • 06 May 22
LIBERUM: CMO Group* - 2021 accomplished, 2022 started well


Companies: CMO Group PLC
  • 11 May 22
1Spatial - Going to California with Caltrans on my mind

1Spatial continues its US expansion with the announcement of a contract win to support replacing the Transportation System Network (TSN) for the California Department of Transportation (Caltrans). The contract is worth c $1.4m over four years, including US$0.7m in software licence revenue, and was won in partnership with Rizing, a global SAP partner. The US market is a key growth engine for 1Spatial and the Caltrans win shows its strategic plan continues to bear fruit. This contract follows othe

Companies: 1Spatial Plc
  • 27 Apr 22
LIBERUM: 1Spatial* - Strong FY22 Results


Companies: 1Spatial Plc
  • 17 May 22
Hybridan Small Cap Feast 17/05/22

e client of Hybridan LLP Dish of the day Joiners: BSF Enterprise. Following the successful reverse takeover of 3D Bio-Tissues Limited, a tissue engineering business based in Newcastle, UK, the Company announces admission of the enlarged group to the standard segment of the Official List and initiation of trading on the Main Market under the ticker ' BSFA '. The Admission follows a placing which raised £1.75m at a placing price of 7.37 pence per share. Leavers: No Leavers Today. What’s cooking in

Companies: VANL TYM ACSO CCS FNTL SOLI TRAC ECK KIBO OSI